Old Mutual Customised Solutions’s BioMarin Pharmaceuticals BMRN Stock Holding History

Old Mutual Customised Solutions’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$811K	Sell	8,610 -1,400	-14%	-$123K	0.08%	284
2018 Q1	$812K	Buy	10,010 +1,600	+19%	+$137K	0.08%	289
2017 Q4	$750K	Buy	8,410 +3,300	+65%	+$287K	0.08%	308
2017 Q3	$476K	Hold	5,110	–	–	0.06%	340
2017 Q2	$464K	Hold	5,110	–	–	0.07%	330
2017 Q1	$449K	Buy	5,110 +810	+19%	+$72.1K	0.07%	330
2016 Q4	$356K	Buy	4,300 +1,900	+79%	+$163K	0.07%	349
2016 Q3	$222K	Hold	2,400	–	–	0.06%	358
2016 Q2	$187K	Hold	2,400	–	–	0.05%	444
2016 Q1	$198K	Hold	2,400	–	–	0.05%	426
2015 Q4	$251K	Buy	2,400 +200	+9%	+$20.9K	0.06%	351
2015 Q3	$232K	Hold	2,200	–	–	0.06%	362
2015 Q2	$301K	Buy	2,200 +600	+38%	+$74.4K	0.07%	353
2015 Q1	$199K	Buy	1,600 +1,300	+433%	+$138K	0.05%	444
2014 Q4	$27K	Buy	+300	New	+$24.9K	0.01%	678
2014 Q3	–	Sell	-600	Closed	-$37K	–	720
2014 Q2	$37K	Hold	600	–	–	0.01%	710
2014 Q1	$41K	Hold	600	–	–	0.01%	707
2013 Q4	$42K	Hold	600	–	–	0.01%	713
2013 Q3	$43K	Hold	600	–	–	0.01%	698
2013 Q2	$33K	Buy	+600	New	+$37.4K	0.01%	873

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Old Mutual Customised Solutions's BMRN Position: Q2 2018 in Review

Old Mutual Customised Solutions reduced its BioMarin Pharmaceuticals (BMRN) stake by 14% in Q2 2018, selling an estimated $123K and leaving 8,610 shares worth $811K. The position accounts for 0.08% of the portfolio, ranked #284.

Old Mutual Customised Solutions first reported a position in BMRN in Q2 2013 and has held it in 20 quarters since. The position peaked at $812K in Q1 2018. 449 funds tracked by Wall St. Rank hold BMRN as of Q2 2018.

Old Mutual Customised Solutions held 8,610 shares of BioMarin Pharmaceuticals worth $811K as of Q2 2018.
Old Mutual Customised Solutions sold 1,400 BioMarin Pharmaceuticals shares in Q2 2018, an estimated $123K.
BioMarin Pharmaceuticals made up 0.08% of Old Mutual Customised Solutions's portfolio in Q2 2018, its #284 holding.
Old Mutual Customised Solutions first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
Old Mutual Customised Solutions's BioMarin Pharmaceuticals position peaked at $812K in Q1 2018.
449 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2018.

Based on Old Mutual Customised Solutions's 13F filing for Q2 2018, filed 14 Aug 2018.